, Volume 58, Supplement 2, pp 372–373 | Cite as

Antipneumococcal Activity of Gatifloxacin by Agar Dilution MIC

  • Dianne B. Hoellman
  • Michael R. Jacobs
  • Peter C. Appelbaum
Poster Presentations Extended Abstract


  1. 1.
    Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae — an overview. Clin Infect Dis 1992; 15: 77–83PubMedCrossRefGoogle Scholar
  2. 2.
    Jacobs MR, Appelbaum, PC. Antibiotic-resistant pneumococci. Rev Med Microbiol 1995; 6: 77–93CrossRefGoogle Scholar
  3. 3.
    Breiman RF, Butler JC, Tenover FC, et al. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994; 271: 1831–5PubMedCrossRefGoogle Scholar
  4. 4.
    Doern GV, Brueggemann A, Holley HP, et al. Antimicrobial resistance of Streptococcus pneumoniae isolated from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996; 40: 1208–13PubMedGoogle Scholar
  5. 5.
    Block S, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995; 14: 751–9PubMedCrossRefGoogle Scholar
  6. 6.
    Pankuch GA, Jacobs MR, Appelbaum PC. Activity of CP 99,219 compared to DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci. J Antimicrob Chemother 1995; 35: 230–2PubMedCrossRefGoogle Scholar
  7. 7.
    Hosaka M, Kinoshita S, Toyama A, et al. Antibacterial properties of AM-1155, a new 8-methoxy quinolone. J Antimicrob Chemother 1995; 36: 293–301PubMedCrossRefGoogle Scholar
  8. 8.
    Hosaka M, Yasue T, Fukuda H, et al. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother 1992; 36: 2108–17PubMedCrossRefGoogle Scholar
  9. 9.
    Nakashima M, Uematsu T, Kosuge K, et al. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrob Agents Chemother 1995; 39: 2635–40PubMedCrossRefGoogle Scholar
  10. 10.
    Wakabayashi E, Mitsuhashi S. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone. Antimicrob Agents Chemother 1994; 38: 594–601PubMedCrossRefGoogle Scholar
  11. 11.
    Wise R, Brenwald NP, Andrews JM, et al. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones. J Antimicrob Chemother 1997; 39: 447–52PubMedCrossRefGoogle Scholar
  12. 12.
    Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother 1997; 40: 639–51PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  • Dianne B. Hoellman
    • 1
  • Michael R. Jacobs
    • 2
  • Peter C. Appelbaum
    • 1
  1. 1.Department of PathologyHershey Medical CenterHersheyUSA
  2. 2.Department of PathologyCase Western Reserve UniversityClevelandUSA

Personalised recommendations